AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
AMA Update for Dec. 20, 2023: Ozempic for weight loss, Zepbound JAMA study, new sickle cell treatments and Medicare payment cuts
·
12 Min Read

Ozempic for weight loss, Zepbound JAMA study, new sickle cell treatments and Medicare payment cuts

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Ozempic for weight loss, sickle cell treatments and more.

series
Chronic Diseases
AMA Update
·
12 Min Read

Ozempic for weight loss, Zepbound JAMA study, new sickle cell treatments and Medicare payment cuts [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Ozempic for weight loss, sickle cell treatments and more.

series
Chronic Diseases
AMA Update Podcast
AMA Update for Nov. 22, 2023: CDC's Antibiotic Awareness Week with Priya Nori, MD
·
9 Min Read

CDC's Antibiotic Awareness Week with Priya Nori, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about antibiotic resistance.

series
Behavioral Health
AMA Update
·
9 Min Read

CDC's Antibiotic Awareness Week with Priya Nori, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about antibiotic resistance.

series
Behavioral Health
AMA Update Podcast
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Nov. 13, 2023

In the news: Life expectancy gap grows, semaglutide reduced CV risk for patients with obesity, unsafe eyedrops removed from Amazon and more. 

Publications & Newsletters
·
3 Min Read

AMA strengthens policy to address growing national drug shortages

New policy aimed at diversifying drug manufacturing, supply chains and stabilizing generic drug market to combat drug supply shortages.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Nov. 6, 2023

In the news: FDA handling of drug shortage under investigation, congenital syphilis on the rise, childhood vaccine exemptions hit record high and more.

Publications & Newsletters
Smiling patient in conversation with health care worker
·
4 Min Read

Despite metformin’s benefits for prediabetes, Rx rates lag

Data from 50,000 patients shows that few of those at higher risk are prescribed the drug shown to help prevent progression to diabetes.

Prevention & Wellness
·
1 Min Read

AMA applauds DEA extending telehealth prescription flexibilities through 2024

The AMA applauds the DEA decision to extend flexibilities in the prescribing of controlled substances based on telehealth patient visits through December 31, 2024

Press Releases